Rituximab in combination with CNOP chemotherapy in patients withn previously untreated indolent non-Hodgkin's lymphoma

MLA

Economopoulos, T., et al. Rituximab in Combination with CNOP Chemotherapy in Patients Withn Previously Untreated Indolent Non-Hodgkin’s Lymphoma. Jan. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7974c794fcbfe46d060687abd7141031&authtype=sso&custid=ns315887.

APA

Economopoulos, T., Fountzilas, G., Pavlidis, N., Kalantzis, D., Papageorgiou, E., Christodoulou, C., Hamilos, G., Nikolaides, C., & Dimopoulos, M. A. (2003). Rituximab in combination with CNOP chemotherapy in patients withn previously untreated indolent non-Hodgkin’s lymphoma.

Chicago

Economopoulos, T., George Fountzilas, Nicholas Pavlidis, Dimitrios Kalantzis, E. Papageorgiou, C. Christodoulou, G. Hamilos, C. Nikolaides, and M. A. Dimopoulos. 2003. “Rituximab in Combination with CNOP Chemotherapy in Patients Withn Previously Untreated Indolent Non-Hodgkin’s Lymphoma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7974c794fcbfe46d060687abd7141031&authtype=sso&custid=ns315887.